Author: Ash

Portola Pharmaceuticals Inc (NASDAQ:PTLA) To Issue Corporate Update Next Month

Dec 23, 2018 | Business

Portola Pharmaceuticals Inc (NASDAQ:PTLA) reported that Scott Garland, the Chief Executive Officer...

Read More

What Is Going On With Intrexon Corp (NASDAQ:XON) Subsidiary?

Dec 23, 2018 | Business

Precigen, Inc., a subsidiary unit of Intrexon Corp (NASDAQ:XON) reported that the U.S. FDA has...

Read More

1
2

Categories

Recent Articles

Selecta Biosciences Inc (NASDAQ:SELB) Expands Potential for ImmTOR Platform As Well As Its Streamlined Structure
Jan 18, 2019 | Business
Regenxbio Inc (NASDAQ:RGNX) Sees a Continued Progress Across Programs; With Promising Results on RGX-314 for The Wet Age-Related Macular Degeneration
Jan 18, 2019 | Business
Inhibrx Developing CAR T Cell Immunotherapies In Collaboration With bluebird bio Inc (NASDAQ:BLUE)
Jan 18, 2019 | Business
Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) Lunches Phase 1B/2 Clinical Trial of Rebastinib Combined with Carboplatin in Solid Tumors
Jan 18, 2019 | Business
Positive Top-Line Data From Phase 2 Study For CSU Is A Good Sign For Allakos Inc. (NASDAQ:ALLK)
Jan 18, 2019 | Business

JOIN OUR FREE NEWSLETTER FOR UPDATES AND LATEST BIO STOCK NEWS.

PRIVACY POLICY | DISCLAIMER